Get the facts straight??? *LAUGHING* How can you

New Post Public Reply Private Reply Replies (0) Message Board
nonsequetor
1,091
Get the facts straight???

*LAUGHING*

How can you possibly get this wrong???

OR

Would you really try to misrepresent the facts???

"Say it ain't so, Joe..."

WHEREAS Plaintiffs Pharma Tech Solutions, Inc. and Decision IT Corp. (collectively
“Pharma Tech”) have alleged in this action, inter alia, that Defendants LifeScan Inc., LifeScan
Scotland, Ltd. and Johnson & Johnson (collectively, “LifeScan”) literally infringe U.S. Patent Nos.
6,153,069 (“the ’069 patent”) and 6,413,411 (“the ’411 patent”) (collectively, the “Asserted
Patents”) by making, using, importing, exporting, offering to sell, and selling OneTouch Ultra blood
glucose test strips and meters (the “Accused Products”); and
WHEREAS LifeScan has disputed this allegation; and
WHEREAS LifeScan has provided Pharma Tech with access to documentation showing the
operation of the Accused Products; and
WHEREAS Pharma Tech has reviewed this documentation and has concluded that LifeScan
does not literally infringe the Asserted Patents by making, using, importing, exporting, offering to
sell, or selling the Accused Products; and
WHEREAS Pharma Tech now wishes to dismiss its allegations of literal infringement;
NOW THEREFORE, IT IS HEREBY STIPULATED, AGREED, AND ORDERED that
Pharma Tech’s claims against LifeScan of literal infringement of all claims of the ’069 patent and all
claims of the ’411 patent ARE DISMISSED WITH PREJUDICE.

For clarity and the avoidance of doubt, this Stipulation and Order does not in any way affect
Pharma Tech’s claim that LifeScan infringes the ’411 patent and the ’069 patent under the doctrine
of equivalents.
Dated: June 6, 2017


EVANS FEARS & SCHUTTERT L.L.P.
/s/ Chad R. Fears
Chad R. Fears, NV Bar No. 6970
Kelly A. Evans, NV Bar No. 7691
2300 West Sahara Avenue
Suite 1130
Las Vegas, NV 89102
Gregory Diskant (pro hac vice)
Eugene M. Gelernter (pro hac vice)
PATTERSON BELKNAP WEBB & TYLER LLP
1133 Avenue of the Americas
New York, NY 10036
Charles D. Hoffmann (pro hac vice)
Sean R. Marshall (pro hac vice)
HOFFMANN MARSHALL & STRONG LLP
116 W 23rd Street, Suite 500
New York, NY 10011
Attorneys for Defendants LifeScan, Inc.;
LifeScan Scotland, Ltd.; and Johnson &
Johnson
FOX ROTHSCHILD LLP
/s/ William Rudy
William Rudy (pro hac vice)
1225 17th St., Ste. 2200
Denver, CO 80202

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading